Search Results
Mar 23, 2026, 07:24 ET Interna Therapeutics Announces Human Challenge Trial Agreement with the University of Oxford to Advance Intranasal MNM-siRNA SARS-CoV-2 Prophylaxis Program
and peptides – into cells and tissues that have historically been difficult to access. Interna is advancing programs in respiratory viral infections, rare diseases, and oncology.
More news about: Interna Therapeutics
Mar 23, 2026, 07:00 ET Summit Explore Signs Term Sheet with Power Minerals to Develop Multi-Salar Lithium Project in Argentina
mining leases covering 147 square kilometres in Salta Province, Argentina, within the Lithium Triangle. Power Minerals also holds the Santa Anna niobium-rare earth-gallium project in Goiás State, Brazil, and exploration assets in South Australia. The company was incorporated in 2002 and is headquartered in
More news about: Summit Explore Corporation
Mar 23, 2026, 07:00 ET BioLineRx Reports 2025 Financial Results and Provides Corporate Update
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2025, and provided a corporate update.
More news about: BioLineRx Ltd.
Mar 23, 2026, 07:00 ET Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
6 and durable culture conversion at Month 15.About MAC Lung DiseaseMycobacterium avium complex (MAC) lung disease is a rare and serious disease that can significantly increase morbidity and mortality. Patients with MAC lung disease can experience a range of symptoms that
More news about: Insmed Incorporated
Mar 23, 2026, 06:26 ET Karmanos Cancer Institute Becomes First and Only Free-Standing Cancer Center to Treat Hemophilia B with New Gene Therapy
have some days where I was just tired, but about a week after the infusion, I was good."What is Hemophilia B?Hemophilia B is a rare blood-clotting disorder caused by a deficiency of factor IX, a clotting protein. As a result, hemophilia B patients may have excessive bleeding after
More news about: Karmanos Cancer Institute
Mar 23, 2026, 01:48 ET Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients
Chief Science Officer of Belief BioMed, said, "Belief BioMed focuses on the cutting-edge gene therapy field, with our product pipeline covering the rare and common diseases, striving to fill a large number of unmet clinical needs. In 2025, we successfully launched China's first gene therapy for Hemophilia
More news about: Belief BioMed
Mar 22, 2026, 08:33 ET RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc ("Ultragenyx" or the "Company") (NASDAQ: RARE) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 21, 2026, 16:55 ET Medicus IT Appoints Shelby Kobes as Senior Director of Nonprofit & Community Health
Medicus IT, said, "The regulatory and cybersecurity demands facing nonprofit and community health organizations have never been greater. Shelby has a rare combination of deep technical expertise and trusted relationships across the CHC community. His appointment reinforces our commitment to serving highly
More news about: Medicus IT
Mar 21, 2026, 13:28 ET TTW Reveals Top 50 Safest Travel Destinations Around the World for 2026
Finland's largest lake region, famous for peaceful nature, island scenery, and rare Saimaa ringed seals.Travel by train or car from
More news about: Travel And Tour World
Mar 20, 2026, 22:29 ET Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE), if they purchased or otherwise acquired the Company's shares between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"). This action
More news about: ClaimsFiler
Mar 20, 2026, 16:30 ET QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
history as a comparator.Ineligibility for "Plausible Mechanism" Pathway: The official disputed AMT-130's eligibility for streamlined rare-disease pathways, noting it is not an individualized treatment.The recent reports follow the filing of a securities class action suit.Investors
More news about: Hagens Berman Sobol Shapiro LLP
Mar 20, 2026, 16:20 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
oral tablet intended to treat hyperphagia. Soleno has described this condition as "the most life-limiting aspect" of Prader-Willi Syndrome ("PWS"), a rare genetic disorder that causes physical, mental, and behavioral problems.The report triggered a massive 26% selloff in the price of the company
More news about: Hagens Berman Sobol Shapiro LLP
Mar 20, 2026, 15:44 ET /C O R R E C T I O N -- Four Seasons Hotels and Resorts/
open-air design, creating a relaxed setting for daytime gatherings. Bar O offers a more intimate, design-forward lounge dedicated to craft cocktails and rare spirits, inviting guests to linger over a nightcap in an elegant setting.Wellness Experiences Guided by the Five Elements of VitalityWellness
More news about: Four Seasons Hotels and Resorts
Mar 20, 2026, 12:58 ET PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing since 2020.1About PANTHERx RarePANTHERx Rare makes rare disease care more hyper-personalized and less overwhelming by focusing relentlessly on each patient and each therapy. PANTHERx experts
More news about: PANTHERx Rare Pharmacy
Mar 20, 2026, 12:26 ET NASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc.
INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:Soleno is a pharmaceutical company focused on developing therapies for rare diseases and is headquartered in Redwood City, California. At the time of the filing of the complaint, Soleno's only commercial product was diazoxide
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 20, 2026, 11:53 ET /C O R R E C T I O N -- The Galien Foundation/
categories: "Best Biotechnology Product", "Best Digital Health Solution", "Best Medical Technology", "Best Pharmaceutical Product", "Best Product for Rare/Orphan Diseases", "Best Public Sector Innovation", and "Best Startup.""It is a true honor to recognize the achievements of this year's Modi Prix
More news about: The Galien Foundation
Mar 20, 2026, 10:33 ET ASTTU and Georgia AFL-CIO Launch Workforce Stability Initiative to Protect Skilled Labor
they need to step away and recover from years of sustained physical labor. In many skilled trades, long term musculoskeletal deterioration is not a rare event. It is an expected outcome of decades on the job. These situations often do not qualify as workers' compensation claims, even though they stem
More news about: Association of Skilled Trade and Transportation Unions (ASTTU)
Mar 20, 2026, 10:16 ET Linear Actuators Market Set for USD 87 Billion Milestone as Electrification Replaces Legacy Hydraulics; New Analysis by Maximize Market Research Highlights 7.5% CAGR through 2032
actuators innovation, particularly in the aerospace and medical sectors. U.S.-based manufacturers are increasingly reshoring production to secure 'Rare-Earth Free' magnet supply chains, mitigating dependencies on global processing monopolies. This dual-track growth ensures that while APAC drives
More news about: Maximize Market Research Pvt. Ltd.
Mar 20, 2026, 10:00 ET GENIES AND SANRIO® ANNOUNCE COLLABORATION FOR INTERACTIVE AI-ENABLED CHARACTER EXPERIENCES
process to ensure every character remains true to its origins and the brand fans have cherished for decades."Sanrio has built something truly rare, a universe of characters that fans carry with them across every stage of their lives," said Akash Nigam, CEO and Founder of Genies. "At Genies, our
More news about: Genies
Mar 20, 2026, 09:18 ET Suunto Vertical Week mobilizes global community for Protect Our Winters Europe
supporting physical health, and employment and tax contributions. The negative impacts are on a similar level to any electronics company and linked to rare raw material extraction and electronics waste. We continuously follow changes in the operational context and international regulations to improve our
More news about: Suunto
Mar 20, 2026, 09:00 ET Old Forester Unveils Newest Expansion in The 117 Series: High Angels' Share Rye Kentucky Straight Rye Whiskey
conditions, certain barrels occasionally yield an elevated evaporative loss, affectionately known as the angels taking more than their fair share. From these rare barrels comes this special rye whiskey, a small batch of casks that have developed intensely flavorful and concentrated profiles, truly the "chosen
More news about: Old Forester
Mar 20, 2026, 09:00 ET NeutronX Appoints Former Microsoft Senior Director of AI and Global Partnerships and Former Director of Microsoft Cities Scott Mauvais to Advance AI-Driven Energy and Microgrid Infrastructure with NextNRG (NASDAQ: NXXT)
execution partner for government contracts secured by NeutronX in targeted federal energy and defense infrastructure projects."Scott brings a rare combination of experience across AI, cities, partnerships, and applied infrastructure innovation," said Emilio T. Gonzalez, Ph.D., President of NeutronX.
More news about: NeutronX Corporation and NextNRG, Inc.
Mar 20, 2026, 08:39 ET Shopping Guide for Mom, Dad, and Pet Parents: Expert-Approved Gifts That Deliver Yum, Joy, Beauty, Health & More
Simply Divine – This luscious skin oil blends exotic ingredients from around the world, including rare helichrysum ("immortelle"), long treasured for its restorative properties.Jennifer Tobler |
More news about: Consumer Product Events
Mar 20, 2026, 08:20 ET Significant 45.5± Acre New Jersey Development Parcel to be Sold at Absolute Auction by Tranzon Alderfer Auction Company
settlement agreement that describes the development potential."This exceptional property, situated next to an expansive open space, offers a rare combination of privacy, tranquility, and nature beauty, making it ideal for a private estate or thoughtfully planned residential community." said
More news about: Tranzon
Mar 20, 2026, 08:03 ET Omni Consumer Products Founder Builds 3D, Fully Interactive, Blade Runner Voight-Kampff Machine in 90 Minutes Using AI, Highlights Three Human Skills That Will Define the Future Human Workforce
per engineer per day on AI tokens have room to improve—tells the same story from the supply side. The tools exist, but consistent application remains rare. Creativity without tenacity remains conceptual; communication without tenacity produces briefs that never ship."Stop hiring for tool proficiency—the
More news about: Omni Consumer Products